Portal de Periódicos da CAPES

Donor-transmitted coronary atherosclerosis

2003; Elsevier BV; Volume: 22; Issue: 5 Linguagem: Inglês

10.1016/s1053-2498(02)00655-1

1557-3117

Onnen Grauhan, Johannes Patzurek, Manfred Hummel, H. Lehmkuhl, Michael Dandel, Miralem Pašić, Yuguo Weng, Roland Hetzer,

Mechanical Circulatory Support Devices

Abstract Background: Autopsies show that coronary atherosclerosis is present frequently in the young and healthy. However, according to our former guideline, we performed pre-transplant evaluation without coronary angiogram in donors <60 years. The purpose of this study is to evaluate to what extent native coronary atherosclerosis is transmitted through heart transplantation. Methods: Between April 1986 and December 2000, a total of 1,253 patients underwent heart transplantation at our institution. If coronary evaluation with coronary angiogram or autopsy had been performed within 6 months after transplantation, we regarded focal and non-circumferential atherosclerosis with ≥50% stenosis in proximal segments of at least 1 coronary vessel of the donor heart as transmitted, native coronary atherosclerosis, rather than newly developed transplant vasculopathy. Results: We excluded 85 of 1,253 (6.8%) cases because coronary evaluation was not performed within 6 months ( n = 45) or because hearts underwent angiography during pre-transplant evaluation ( n = 40). Of these, 2 patients with significant coronary atherosclerosis underwent transplantation and concurrent coronary artery bypass grafting. The prevalence of significant (stenosis ≥50%) and inadvertently transmitted coronary atherosclerosis was 7.0% (82/1,168). The prevalence of coronary atherosclerosis in patients who underwent angiography within 6 months after transplantation was 5.2% (49/950). Among subjects who had autopsies within the first 6 months after heart transplantation, we found significant coronary atherosclerosis (stenosis ≥50%) 15.1% (33/218), and among those with early graft failure (<10 days after transplantation), the prevalence was 22.8% (26/114). Conclusion: The prevalence of coronary atherosclerosis in the donor pool is high, and donor screening without coronary angiogram overlooks significant coronary atherosclerotic lesions (stenosis ≥50%) in a considerable number of cases (7.0%). Because donor-transmitted coronary atherosclerosis is a risk factor in short-term (early graft failure) survival after heart transplantation, we have now changed our policy to include coronary angiography as a standard in screening donors ≥40 years. However, to what extent donor coronary atherosclerosis is accepted undoubtedly must be made arbitrarily until an evidence-based algorithm becomes available.